Keystone Symposia
Home | My Account | Shopping Cart  0
  Advanced
     facebook  twitter

LANGUAGE NOTE: This meeting will be conducted in English.
Register YourselfRegister a Colleague


Meeting Program

To view program in "24 hour" time (international) click here.


Sunday, June 6
3:00 - 7:30 PM Registration
6:30 - 7:30 PM Refreshments
7:30 - 8:30 PM Keynote Address
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Osamu Hayaishi, Osaka Bioscience Institute, Japan
Prostaglandins and Sleep
Monday, June 7
7:30 - 8:30 AM Breakfast
7:30 - 8:30 AM Poster Setup
8:30 AM- 3:00 PM Poster Viewing
8:30 - 11:30 AM Biochemistry of Lipid Metabolism I
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Takao Shimizu, University of Tokyo, Japan
Turnover of glycerophospholipids by deacylation-reacylation cycle
Makoto Murakami, Tokyo Metropolitan Institute of Medical Science, Japan
Biological Functions of sPLA2s
John Turk, Washington University School of Medicine, USA
Studies of Genetically Modified Mice with Altered Group VIA/VIB PLA2 Expression
William L. Smith, University of Michigan, USA
Cyclooxygenase Homodimers Function as Conformational Heterodimers with Allosteric and Catalytic Subunits
Short Talk(s) to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break
11:30 - 12:30 AM Lunch
12:00 - 2:30 PM Poster Session 1
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
2:30 - 3:00 PM Coffee Available
3:00 - 5:00 PM Biochemistry of Lipid Metabolism II
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Kikuko Watanabe, University of East Asia, Japan
A Novel Type of PGF Synthase belonging to the Thioredoxin-like Superfamily
Jesper Z. Haeggstrom, Karolinska Institute, Sweden
Structure and Function of LTA4 Hydrolase, LTC4 Synthase, and Related Enzymes
B. Therese Kinsella, University College Dublin, Ireland
BIOCHEMISTRY OF THE HUMAN PROSTACYCLIN RECEPTOR.
Short Talk to be Chosen from Abstracts,
Tuesday, June 8
7:30 - 8:30 AM Breakfast
8:30 - 11:30 AM Biochemistry of Lipid Metabolism III
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Robert C. Murphy, University of Colorado Denver, USA
Transcellular Biosynthesis of Leukotrienes in vivo
Alan R. Brash, Vanderbilt University Medical Center, USA
Lipoxygenases, Essential Fatty acids, and the Epidermis
Michal L. Schwartzman, New York Medical College, USA
Cytochrome P450-Derived EETs and HETEs in Vascular Biology
Junkin Aoki, Tohoku University, Japan
Autotaxin and LPA Signaling in Cardiovascular Development
Short Talk(s) to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break
11:30 AM- On Own for Lunch and Recreation
11:30 AM- 1:30 PM Poster Setup
1:30 - 10:00 PM Poster Viewing
4:30 - 5:00 PM Coffee Available
5:00 - 7:00 PM Immunoregulation
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Shuh Narumiya, Kyoto University, Japan
Prostanoids and Immune Inflammation
Kenji Chiba, Mitsubishi Tanabe Pharma Corporation, Japan
Immunoregulation by the Sphingosine 1-Phosphate Receptor Modulator, FTY720
Andreas Zimmer, University of Bonn, Germany
Endocannabinoids and Immunoregulation
Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM Social Hour w/ Lite Bites
7:30 - 10:00 PM Poster Session 2
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Wednesday, June 9
7:30 - 8:30 AM Breakfast
8:30 - 11:30 AM Allergy and Inflammation
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
K. Frank Austen, Harvard Medical School, USA
The Integrated Biology of the Cysteinyl Leukotrienes and their Receptors
Andrew D. Luster, Massachusetts General Hospital, USA
Lipid-Cytokine-Chemokine Cascades Control Leukocyte Trafficking in Disease
Jilly F. Evans, Amira Pharmaceuticals, USA
Development of FLAP inhibitors
Sarah Spiegel, Virginia Commonwealth University School of Medicine, USA
Novel Intracellular Targets of Sphingosine-1-Phosphate
Short Talk(s) to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break
11:30 AM- On Own for Lunch and Recreation
11:30 AM- 1:30 PM Poster Setup
1:30 - 10:00 PM Poster Viewing
4:30 - 5:00 PM Coffee Available
5:00 - 6:20 PM Nervous System
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Jerold J. Chun, The Scripps Research Institute, USA
Lysophospholipid Signaling in Disease
Daniele Piomelli, University of California, Irvine, USA
Endocannabinoids and the Brain
6:20 - 7:00 PM Cardiovascular Diseases I
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Shaun R. Coughlin, University of California, San Francisco, USA
S1P Signaling and the Cardiovascular System
Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM Social Hour w/ Lite Bites
7:30 - 10:00 PM Poster Session 3
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Thursday, June 10
7:30 - 8:30 AM Breakfast
8:30 - 11:30 AM Cardiovascular Diseases II
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Garret A. FitzGerald, University of Pennsylvania, USA
Cardiovascular Biology of the Prostanoids
Colin D. Funk, Queen's University, Canada
Eicosanoids in Cardiovascular Disease
Paola Patrignani, G. D'Annunzio University, Italy
Role of Prostanoids in Endothelial Biology
Alison M. Strack, Merck & Co., USA
Niacin and DP1 Antagonists: Studies in Mouse Models of Atherosclerosis
Short Talk(s) to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break
11:00 AM- On Own for Lunch and Recreation
4:30 - 5:00 PM Coffee Available
5:00 - 7:00 PM Immunomodulation by Lipid Mediators and Related Drugs
Registered attendees for this meeting can view Abstracts for this session starting on 05/06/2010
Suzanne Ostrand-Rosenberg, University of Maryland, USA
Prostaglandin E2 Drives Immune Suppression in the Tumor Microenvironment
Yoshihiro Urade, Osaka Bioscience Institute, Japan
PGD2 in neuroinflammation and musclar dystrophy
Takayuki Maruyama, Minase Research Institute, Ono Pharmaceutical Co.Ltd., Japan
Possibilities of EP Agonists and Antagonists for Novel Therapies
Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM Social Hour w/ Lite Bites
8:00 - 11:00 PM Entertainment
Friday, June 11
Departure
      *=Session Chair     †=Speaker invited, not yet responded.



Keystone Symposia would like to thank the sponsors of this meeting for their generous support:

We gratefully acknowledge additional support for this conference from:








Asubio Pharma Co., Ltd.



Journal of Lipid Research



Minase Research Institute, Ono Pharmaceutical Co. Ltd.


Ono Pharmaceutical Co.Ltd.


We gratefully acknowledge the generous grant for this conference provided by:

National Institutes of Health
National Institute of Allergy and Infectious Diseases (NIAID)

Grant No. 1R13AI088818-01


The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...

Click here to view these companies

The world of lipid mediators is expanding. New and unexpected biological functions, biosynthetic pathways and receptors are being revealed for lipids as appreciation of their complex interactions with protein and DNA are appreciated. New actions are still being added to classic mediators such as prostaglandins and leukotrienes. Lipid mediators are now recognized to influence a broad swath of biology from inflammation to allergy, immunity, cardiovascular diseases, cancer and behavior. Advances in lipidomics enable us to monitor dynamics of a variety of lipid mediators simultaneously. In this symposium we invite distinguished scientists to share their progress in this expanding field and to present a comprehensive view on what lipid mediators do in our body. We invite also scientists interested in the translation of such basic science from model systems to an understanding of the role of lipids in human physiology, disease and drug action. Expansion of our understanding of the role of lipid mediators affords the opportunity for novel therapeutic opportunities, examples of which will be discussed in the symposium.